Brianna Allen
Brianna is a Senior Director on PhRMA’s Public Affairs team focusing on communications strategies and activities around Medicare, Medicaid and access to medicines. Prior to joining PhRMA, she served as a strategic communications advisor at the FDA’s Center for Devices and Radiological Health and worked as a director of strategic communications on FGS Global’s health care team. She started her career in journalism and spent nearly a decade covering domestic policy issues, including federal health policy for POLITICO. She enjoys spending time outdoors exploring Northern Virginia with her husband, two toddlers and corgi puppy.
Nearly 1 in 4 patients initially denied access to IRA medicines
MFN could disrupt the affordable medicines patients depend on
MFN won’t lower costs when insurers call the shots
MFN price controls would drain pensions and put retirements at risk
CMS’ MFN proposals won’t help seniors despite lofty promises
Hospitals drive nearly 80% of the U.S. health spending gap
MFN drug pricing risks reviving a harmful metric the U.S. rejected
CMS puts patients and innovation at risk with MFN
New list of selected drugs highlights growing consequences of government price setting
Price setting policies put cancer gains in jeopardy
Myth vs. Fact: How government price setting impacts innovation
Celebrating 60 Years of Medicare
Foreign first pricing schemes don’t address why Americans pay more
New analysis: Fewer treatments and cures under the IRA’s pill penalty
Three reasons Congress should fix the IRA’s pill penalty
Brianna Allen headshot